This adaptive dosing program is designed to find the ideal dose for each individual, minimizing unnecessary drug exposure and side effects
Some medications and health conditions may require adjustments or extra monitoring when using GLP-1 products
Hypertension is the most common preventable risk factor for CVDs (including coronary heart disease, heart failure, stroke, myocardial infarction, atrial fibrillation, and peripheral artery disease), chronic kidney disease, and cognitive impairment, and also the main single factor for deaths and disability worldwide (133)
With a more convenient oral formulation, Novo can position itself as a competitor to traditional diabetes medications, such as metformin, sulfonylureas, and SGLT2 inhibitors that are taken by mouth
The standard dose is 2 mg once weekly, administered on the same day each week regardless of meals
This article is not medical advice